Table 2.
Associations between two TRAP exposures and three allergic diseases in 14,765 children from the Seoul Atopy Friendly School Project Survey in 2010 in Seoul, Korea.
Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|
ORa | 95% CI | ORb | 95% CI | ORc | 95% CI | |
Proximity | ||||||
Atopic eczema | ||||||
≤150 m | 1.16 | (1.02–1.32) | 1.15 | (1.01–1.31) | 1.15 | (1.01–1.32) |
150–300 m | 1.17 | (1.02–1.34) | 1.17 | (1.03–1.34) | 1.17 | (1.03–1.34) |
300–500 m | 1.16 | (1.01–1.33) | 1.16 | (1.01–1.33) | 1.16 | (1.01–1.34) |
>500 m | 1.00 | 1.00 | 1.00 | |||
Asthma | ||||||
0–150 m | 0.95 | (0.80–1.13) | 0.94 | (0.79–1.12) | 0.93 | (0.78–1.11) |
150–300 m | 1.13 | (0.95–1.34) | 1.12 | (0.95–1.33) | 1.11 | (0.93–1.32) |
300–500 m | 1.01 | (0.85–1.21) | 1.01 | (0.84–1.21) | 1.00 | (0.83–1.20) |
>500 m | 1.00 | 1.00 | 1.00 | |||
Allergic rhinitis | ||||||
0–150 m | 0.96 | (0.87–1.05) | 0.96 | (0.87–1.06) | 0.97 | (0.88–1.07) |
150–300 m | 1.03 | (0.93–1.14) | 1.03 | (0.93–1.14) | 1.05 | (0.95–1.16) |
300–500 m | 0.99 | (0.89–1.10) | 1.00 | (0.90–1.10) | 1.00 | (0.90–1.12) |
>500 m | 1.00 | 1.00 | 1.00 | |||
| ||||||
Density for an interquartile range increment (13,120 m 2) | ||||||
Atopic eczema | 1.08 | (1.02–1.16) | 1.08 | (1.01–1.15) | 1.08 | (1.01–1.15) |
Asthma | 0.95 | (0.87–1.05) | 0.95 | (0.87–1.04) | 0.94 | (0.86–1.03) |
Allergic rhinitis | 0.97 | (0.92–1.02) | 0.97 | (0.92–1.03) | 0.97 | (0.92–1.03) |
aOdds ratio (OR) adjusted for sex and age; bOR adjusted for sex, age, household monthly income, body mass index, and history of breastfeeding; cOR adjusted for sex, age, household monthly income, body mass index, history of breastfeeding, and random effects for school and residential area.